38 results
Page 2 of 2
8-K
EX-99.2
251j otk8p1tsgls
12 Nov 19
Reata Pharmaceuticals, Inc. Announces Third Quarter 2019 Financial Results and an Update on Development Programs
6:50am
8-K
EX-99.1
a2w4yczp5lqvby3di480
15 Oct 19
Reata announces positive Topline results from the moxie Registrational trial of omaveloxolone in patients with friedreich’s ataxia
6:45am
8-K
EX-99.2
v2juh 5e1thu7
15 Oct 19
Reata announces positive Topline results from the moxie Registrational trial of omaveloxolone in patients with friedreich’s ataxia
6:45am
8-K
EX-99.2
otdx35bw6g0szn7mp4
25 Sep 18
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl In Iga Nephropathy and Type 1 Diabetic Chronic Kidney Disease
7:05am
8-K
EX-99.1
qxkbe ebynxd7g0u0
25 Sep 18
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl In Iga Nephropathy and Type 1 Diabetic Chronic Kidney Disease
7:05am
8-K
EX-99.1
po5l88xzi5
23 Jul 18
Other Events
7:00am
8-K
EX-99.2
hnbezf g0f77h5c
23 Jul 18
Other Events
7:00am
8-K
EX-99.3
abi6ie2d34y1i
25 May 18
Other Events
6:03am
8-K
EX-99.2
nnzdvy igjo4g13
25 May 18
Other Events
6:03am
8-K
EX-99.1
hqtza7hd
25 May 18
Other Events
6:03am
424B5
xqwvkt zwbv4
27 Jul 17
Prospectus supplement for primary offering
12:00am